In cancer and transformed cells, the alternative splicing of FN is increased, leading to an increased expression of ~ 20 different FN isoforms that contain one or more domains (Ebbinghaus et al., 2004; Kumra and Reinhardt, 2016; Schiefner et al., 2012). This evidence concerns the gene FN1 and cancer.